Document Classification

Section Type: RESULTS

Text: At M6, rhGH therapy did not significantly affect changes in CIMS or CIMS SDS (height) (+17. 6 % vs +7. 5 % and +0. 14 0. 38 vs +0. 11 0. 62, respectively) ; the rhGH-treated group had significantly larger changes in height SDS (+0. 2 [0. 3] vs -0. 2 [0. 3] ; P = 0. 003), LM (+7. 3 % [+3. 7 % ; +21. 6 %] vs 0 % [-4. 7 % ; +3. 2 %] ; P = 0. 002), and MA (+8. 8 % [+5 % ; +15. 6 %] vs. -0. 6 % [-6. 3 % ; +7. 7 %] ; P = 0. 01) compared with the untreated group.